AstraZeneca enters obesity market with $2b deal for GLP-1 candidate
AstraZeneca has signed an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004, an early-stage investigational...
top of page
Browse by category
Search
AstraZeneca and Regeneron to develop obesity treatments
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...
Browse by tag
bottom of page